Myriad Genetics comments on UnitedHealthcare’s updated policy
Myriad Genetics (MYGN) was informed on Friday, November 1, 2024, of an updated medical policy from UnitedHealthcare restricting access to ...
Myriad Genetics in Active Talks with UnitedHealthcare to Keep Coverage of GeneSight
Myriad Genetics said it is in talks with UnitedHealthcare to ensure that enrollees continue to have access to its GeneSight mental health medication test after the insurer changed its coverage policy.
Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing
SALT LAKE CITY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, was ...
Learning To Achieve Wellness Earns 2024 Best Of Florida Honorable Mention For Holistic Care
BRANDON, FL, UNITED STATES, November 3, 2024 /EINPresswire / -- Learning to Achieve Wellness has carved out a unique space in the world of mental < ...
How are Americans feeling before Election Day?
Election season is in full swing, but as anyone can tell you, campaigns begin to enter their full speed much earlier in the ...
Myriad weakness due to UnitedHealth coverage update, says Stephens
Stephens analyst Mason Carrico notes that Myriad Genetics (MYGN) shares are down about 20% this morning, which the firm ...
UnitedHealth update ‘not the end’ for Myriad’s GeneSight, says Raymond James
UnitedHealth (UNH) on Friday disclosed that it would stop covering multi-panel pharmacogenetic tests, including Myriad’s (MYGN) ...
Myriad Genetics plummets 20% as UnitedHealth changes GeneSight coverage
Myriad Genetics stock plunges after UnitedHealth Group announces they will no longer cover genetic tests for mental health ...